A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Calusterone
Secukinumab
The metabolism of Nabiximols can be increased when combined with Secukinumab.
Calusterone
Certolizumab pegol
The metabolism of Nabiximols can be increased when combined with Certolizumab pegol.
Calusterone
Golimumab
The metabolism of Nabiximols can be increased when combined with Golimumab.
Calusterone
Rilonacept
The metabolism of Nabiximols can be increased when combined with Rilonacept.
Calusterone
Tocilizumab
The metabolism of Nabiximols can be increased when combined with Tocilizumab.
Calusterone
Canakinumab
The metabolism of Nabiximols can be increased when combined with Canakinumab.
Calusterone
Afelimomab
The metabolism of Nabiximols can be increased when combined with Afelimomab.
Calusterone
Oliceridine
The risk or severity of adverse effects can be increased when Nabiximols is combined with Oliceridine.
Calusterone
Remimazolam
The risk or severity of adverse effects can be increased when Nabiximols is combined with Remimazolam.
Calusterone
Carfentanil, C-11
The risk or severity of adverse effects can be increased when Nabiximols is combined with Carfentanil, C-11.
Calusterone
JNJ-26489112
The risk or severity of adverse effects can be increased when Nabiximols is combined with JNJ-26489112.
Calusterone
Bentazepam
The risk or severity of adverse effects can be increased when Nabiximols is combined with Bentazepam.
Calusterone
Pyrazolam
The risk or severity of adverse effects can be increased when Nabiximols is combined with Pyrazolam.
Calusterone
Cinazepam
The risk or severity of adverse effects can be increased when Nabiximols is combined with Cinazepam.
Calusterone
Oxazepam acetate
The risk or severity of adverse effects can be increased when Nabiximols is combined with Oxazepam acetate.
Calusterone
Perphenazine enanthate
The risk or severity of adverse effects can be increased when Nabiximols is combined with Perphenazine enanthate.
Calusterone
Eslicarbazepine
The risk or severity of adverse effects can be increased when Nabiximols is combined with Eslicarbazepine.
Calusterone
Lithium carbonate
The risk or severity of adverse effects can be increased when Nabiximols is combined with Lithium carbonate.
Calusterone
Aripiprazole lauroxil
The risk or severity of adverse effects can be increased when Nabiximols is combined with Aripiprazole lauroxil.
Calusterone
Cannabidivarin
The risk or severity of adverse effects can be increased when Nabiximols is combined with Cannabidivarin.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3